icon_advocacy-orange_0.png
Advocacy
Promoting cancer in global health and development agendas.
Long_Term_Vision_2035_headlines@2x.png

In 2018, an estimated 18.1 million people were newly diagnosed with cancer. It is expected that by 2030, this number will rise to 21.6 million. This alarming trend can be reversed with strong action at global and national level. 

Investing in cancer control, from prevention to treatment and care, can bring about important changes in disease burden by reducing cancer-related illness and death. It is estimated that increased annual international funding of USD 18 billion globally on prevention, earlier detection and improved care for cancer patients could save three million lives per year by 2030 - and many more in the decades beyond.  

What is cancer control advocacy?

Advocacy for cancer control is a strategic process that is designed to influence governments, decision makers and other key stakeholders through the effective use of evidence, to reduce the global cancer burden, to promote greater equity, and to integrate cancer control into the world health and development agenda.

Advocacy at UICC

UICC unites the cancer community through our members and partners to reduce the global cancer burden and drive forward the Non-Communicable Disease (NCD) agenda - building upon key international agreements, such as the Sustainable Development Goals (SDGs), the Global Action Plan on NCDs 2013-2020, the World Cancer Declaration and the 2017 Cancer Resolution -  to ensure that these global goals and targets are translated into national action.

In addition to all countries developing and implementing an appropriately resourced and time-bound national cancer plan, we wish to see measurable improvements in the way that cancers are detected, treated and cured around the world. 

With global cancer burden trends on the rise, advocacy at UICC is shifting its immediate attention to Treatment for All, a campaign emphasising improved data, early detection, treatment and care to meet our global commitment of a 25% reduction in cancer and NCD mortality by 2025.

The importance of the advocacy work

"We are proud to call ourselves one of the first partners of UICC. UICC called on our expertise in the area of cancer prevention for the global advocacy campaign. Together, UICC and its members have successfully placed cancer on the global stage, putting the cancer community in position for even greater success in the years to come.”

Dr Kate Allen, Director, Science and Communications

"Accurate and timely diagnosis is the first enemy of cancer, as it clips its potential from the outset and halts it from invading and conquering the whole body. Unfortunately, many cancer patients, especially in the developing world, do not have this safety net, and are completely exposed to cancer’s advances without any checks. We need a robust cancer resolution that encourages fast improvements in early detection and diagnosis through a clear and urgent health system response."

HRH Princess Dina Mired
Help us &
get involved
icon_advocacy-orange_0.png

Show your support for 

UICC_Resource_Document_Solid_Icon_White-LightOrange_200px.png

the cancer resolution

This month, UICC announced its call for 2019 Country Champions and Mentors. Join the campaign to contribute toward reducing premature mortality and improving patient outcomes. https://www.uicc.org/NationalActivation Together, we can make a difference.

Key advocacy initiatives
WCDec_Report_2016_front_cover.jpg

World Cancer Declaration Progress Report 2016

The 1000-strong UICC membership have worked collectively to create the World Cancer Declaration Progress Report 2016, providing a unique civil society perspective on national successes and major challenges that remain to realise the Declaration targets, with perspectives from 113 countries.

Global Cancer Commitments Navigator

Navigator image.png

The navigator highlights the links between international, time-bound commitments to build compelling arguments for national action on cancer.

Explore our work
Advocacy landscape
Treatment for All
Global Action
National activation
Advocacy networks
Advocacy resources
Last update: 
Wednesday 10 April 2019
Share
Latest advocacy news
Sonali_Johnson.jpg
26 June 2019

Looking back on WHA72 – Key takeaways for the cancer community

This past World Health Assembly (WHA) saw delegates from all 192 WHO member States, along with civil society and other observers come together to discuss key global health issues.

Commissioner of Health and Food Safety, European Union Mr Vytenis Andriukaitis speaking at a World Cancer Day event in Greece .png
30 May 2019

World Cancer Day 2019 mobilises government leaders: The third "Governments in Action Report" released

On the heel of the 72nd World Health Assembly, the World Cancer Day 2019 Governments in Action report has been published. 

Dr Cary Adams speaking at WHA72
23 May 2019

The power of data to drive progress on Universal Health Coverage

23 May 2019 | Geneva, Switzerland – Universal Health Coverage will not be possible without reliable data on births, mortality, health service coverage and other elements. Union for International Cancer Control (UICC) co-hosted a well-attended side event on this topic at the 72nd World Health Assembly.

WHA72 – 23.05.2019
22 May 2019

UICC urges WHO member states to accelerate action on cancer to fulfil the promise of UHC

22 May 2019 | Geneva, Switzerland – WHO Member States agreed three resolutions on universal health coverage on the third day of the 72nd World Health Assembly. They focus on: primary healthcare, the role of community health workers, and the September UN General Assembly high-level meeting on UHC.

IMG_4638.jpg
21 May 2019

UICC called for further investment in prevention, early detection, treatment and palliative care - 72nd World Health Assembly

21 May 2019 | Geneva, Switzerland - Discussions kicked off in earnest today, with Member States examining the WHO’s budget for 2020-2021 as well as the new framework Dr Tedros Adhanom, Director General of the World Health Organization has proposed to analyse how effectively WHO and Member States are meeting their goals. While the proposed budget includes a 5% increase in funding for NCDs (Non-Communicable Diseases), it is not clear where and how this will be divided up across the new WHO structure.

Richard Horton, Editor-in-Chief of the Lancet, speaking at the 72nd World Health Assembly
20 May 2019

72nd World Health Assembly opens with passionate calls for Universal Health Coverage (UHC)

20 May 2019 | Geneva, Switzerland – Addressing inequities in health was front and center during the first day of the 72nd World Health Assembly with other key topics including Universal Health Coverage (UHC), access to medicines and the health and wellbeing of refugees and migrants.